Clinical Trials Logo

Carious Exposure of Pulp clinical trials

View clinical trials related to Carious Exposure of Pulp.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03838094 Completed - Clinical trials for Carious Exposure of Pulp

Evaluation of MTA Versus Biodentine as Pulpotomy Agents in Immature First Permanent Molars

Start date: February 2016
Phase: Phase 1/Phase 2
Study type: Interventional

Aim of the study: To compare the clinical and radiographic outcomes of mineral trioxide aggregate (MTA) and Biodentine as vital pulp therapy materials (pulpotomy) of cariously exposed vital immature mandibular first permanent molars. Materials and Methods: sixty immature first mandibular permanent molars cariously exposed with symptomatic /asymptomatic pulpitis were included in the study according to inclusion criteria and were equally divided in two groups. Following split-mouth design molars were randomly assigned to either a control group (MTA 30 molars) or a test group (Biodentine 30 molars). After conducting pulpotomy and covering pulp stumps with the MTA and Biodentine, treated molars received permanent restorations. Blinded clinical and radiographic evaluations were performed at different time intervals (base line immediate postoperative, 6, 12 and 18 months) according to clinical and radiographic criteria of success. Data were recorded and analysed.